Santyl

Type: Product
Name: Santyl
First reported 1 hour ago - Updated 14 mins ago - 1 reports

Smith & Nephew 2014 Q2 Results

Smith & Nephew plc (LSE: SN, NYSE: SNN) results for the second quarter ended 28 June 2014. An analyst presentation and conference call to discuss Smith & Nephew's second quarter results will be held at 9.00am BST/4.00am EST today, Friday 1 August. This ... [Published Noodls - 1 hour ago]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Updated Summary: SOLUTIONS® wound care algorithm. [ConvaTec]

RecommendationsMajor RecommendationsLevels of evidence ( A-C ) are defined at the end of the "Major Recommendations" field.The recommendations for wound care are presented in the form of 8 algorithms provided at the ConvaTec Web site. Each algorithm corresponds ... [Published National Guideline Clearinghouse - Jun 30 2014]
First reported Feb 05 2014 - Updated Feb 05 2014 - 1 reports

Smith & Nephew Becomes Pharma Family Factor

NEW YORK (TheStreet) -- Any decent management team will tell you that turning around a struggling business is never easy. If that company happens to be in the realm of medical device technology, case studies are rampant. Companies like Boston Scientific ... [Published The Street Latest - Feb 05 2014]

Quotes

" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U S Securities and Exchange Commission under the U S Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations. ◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office."
...and is healing as evidenced by a reduction in size after 2 to 4 weeks of care (Kantor & Margolis, 1998; van Rijswijk & Polansky, 1994; AAWC, "Association for the Advancement of Wound Care guideline of pressure ulcer guidelines" 2010). [ Level A ]

More Content

All (5) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Smith & Nephew 2014 Q2 Results [Published Noodls - 1 hour ago]
Updated Summary: SOLUTIONS® wound care algorith... [Published National Guideline Clearinghouse - Jun 30 2014]
Smith & Nephew Becomes Pharma Family Factor [Published The Street Latest - Feb 05 2014]
PM360 Announces Winners of 2013 Pharma Choice A... [Published PRWeb - Jan 23 2014]
3rd Quarter Results [Published TrustNet - Oct 31 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.